<DOC>
	<DOCNO>NCT00223067</DOCNO>
	<brief_summary>reduce immunsupression introduce tolerance call TAIZ-monocytes renal transplant patient</brief_summary>
	<brief_title>Induction Donor-Specific Tolerance Renal Allograft Recipients ( Living Donor ) With TAIZ-Monocytes</brief_title>
	<detailed_description />
	<criteria>Inclusion Criteria Patients must meet follow inclusion criterion consider admission trial : 1 . Male female adult patient age 18 64 year ( inclusive ) . A female childbearing potential may enrol provide : negative pregnancy test Screening routinely use adequate contraception prior study agree attempt become pregnant study lactate A female nonchildbearing potential define one postmenopausal least one year surgically sterilise . 2 . Patients receive first renal transplant . 3 . Patients fulfil criterion receive allogenic renal transplant ( accord Eurotransplant ( ET ) manual organ allocation Bundes√§rztekammer allocation criterion ) list wait list . 4 . Patients , nature study disclosure data explain , freely give Informed Consent write . 5 . In vitro demonstration suppressive effect donor TAIC donorrecipient pair . Exclusion Criteria ( recipient ) Exclusion Criteria ( recipient ) : Patients present follow exclusion criterion must include trial : 1 . Patients receive renal transplant . 2 . Patients active infection time entry study ( Screening ) . 3 . Recipient donor pair show follow incompatible EBV CMV constellation : donor EBV CMV positive recipient EBV CMV negative . 4 . Patients and/or donor positive evidence HIV active virus hepatitis B C. 5 . Patients history alcohol and/or drug abuse sepsis . 6 . Patients pregnant woman nurse mother . 7 . Known hypersensitivity contraindication one immunosuppressives administer course study : ATG , tacrolimus , steroid ( prednisolone ) . 8 . Patients history present symptom autoimmune vasculitis . 9 . Detection &gt; 5 % HLA antibody ( current historic value ) . 10 . Patients malignancy history malignancy . 11 . Patients renal insufficiency due vasculitis . 12 . Patients whose condition require continuous systemic administration immunosuppressive . 13 . Missing immunosuppressive effect donor TAIC donorrecipient pair vitro test . 14 . Patients simultaneously participate plan participate clinical study . 15 . Psychiatric emotional problem lack knowledge German language would invalidate give Informed Consent limit ability subject comply study requirement . 16 . Unwillingness inability provide Informed Consent participate satisfactorily entire trial period 17 . Patients correspond donor present one exclusion criterion document Eurotransplant guideline ( ) must include trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2004</verification_date>
	<keyword>renal transplantation</keyword>
	<keyword>TAIZ</keyword>
</DOC>